Testing blood and other fluid markers in Duchenne or Becker
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study looks for signals in blood and other body fluids that may help track Duchenne or Becker muscular dystrophy. It may be helpful for patients by improving how future monitoring tests are developed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) confirmed by genetic testing
- You can give informed consent (or your child can provide assent, if needed)
- You must fit the age/sex group: males age 5+ with DMD/BMD, or adults age 18+ with no muscular dystrophy
- You should not be immunosuppressed (a weakened immune system due to medicines or conditions)
- You should not have bleeding/clotting problems, or known liver or kidney disease
- No HIV, and no hepatitis B or hepatitis C infection, as documented in your records
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and, for some people, muscle tissue to look for signs (biomarkers) that can help track and better understand myotonic dystrophy. You may help by providing samples and basic muscle function testing, depending on your age and condition type.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study follows boys with Duchenne muscular dystrophy over time to better understand how the condition changes and how standard treatments affect health and function. It does not appear to test a new medicine, but it may help doctors plan better future care and studies.
This study uses a wearable device to track blood sugar levels and heart rate in people with Duchenne muscular dystrophy. It aims to understand how these factors relate to heart health over time.
This study follows people with Duchenne muscular dystrophy (a muscle-weakening condition) to track how the disease progresses over time. By collecting this data, researchers hope to better understand the condition and improve future care.
This study follows women who have a confirmed DMD gene mutation (a genetic change related to Duchenne/Becker muscular dystrophy) to learn more about health and muscle-related measurements. Depending on the part of the study, you may be asked to take part in MRI or other assessments.
Hear when a new Duchenne Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.